Solano Peña GA, Acurio Armas GF, Díaz Teran GA, Palacios Serrano SP, Cobo Reyes AC, Pullas Taboada DA, Carvajal Chango GK. PCSK9 inhibition: a new alternative to reduce cholesterol and prevent atherosclerotic cardiovascular disease. Salud, Ciencia y Tecnología [Internet]. 2023 Nov. 13 [cited 2024 Jul. 27];3:587. Available from: https://revista.saludcyt.ar/ojs/index.php/sct/article/view/587